Stephanus T. Malherbe

Author

Also Known As

Andre G. Loxton, Karen R Jacobson, Malherbe, Stephanus, Malherbe, Stephanus T., Stephanus T. Malherbe, Stephanus Malherbe, Stephanus T Malherbe, Stephanus T. Malherbe, Stephanus Theron Malherbe

118

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Stellenbosch University South African Medical Research Council University of Cape Town South African Tuberculosis Vaccine Initiative London School of Hygiene & Tropical Medicine

About

Stephanus T. Malherbe is an author at Stellenbosch University specializing in medicine, immunology, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	873
2	Engineering	2	2	161
3	Public Health	2	2	261
4	Allergy	1	1	30
5	Biochemistry	1	1	12

Stephanus T. Malherbe

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure Stephanus T. Malherbe, Shubhada Shenai, Katharina Ronacher, Nature Medicine Pulmonary TuberculosisTuberculosis CureMycobacterium Tuberculosis MrnaTuberculosis PreventionPathology	2016	300
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes Roshni Roy Chowdhury, Francesco Vallania, Qianting Yang, Nature Pulmonary TuberculosisImmunologyClinical EpidemiologyMulti-cohort StudyTuberculosis	2018	243
Host blood RNA signatures predict the outcome of tuberculosis treatment Ethan Thompson, Ying Du, Stephanus T. Malherbe, Tuberculosis	2017	190
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response Adam Penn‐Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, Scientific Reports	2020	157
Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB Novel N. Chegou, Jayne S. Sutherland, Stephanus T. Malherbe, Thorax	2016	156
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial Thomas J. Scriba, Andrew Fioré-Gartland, Adam Penn‐Nicholson, The Lancet Infectious Diseases	2021	141
Diabetes Mellitus Among Pulmonary Tuberculosis Patients From 4 Tuberculosis-endemic Countries: The TANDEM Study César Ugarte‐Gil, Bachti Alisjahbana, Katharina Ronacher, Clinical Infectious Diseases	2019	106
Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results Jayne S. Sutherland, Gian van der Spuy, Awa Gindeh, Clinical Infectious Diseases	2021	106
Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response Ruschca Jacobs, Stephanus T. Malherbe, André G. Loxton, Oncotarget EngineeringLaboratory ImmunologyImmunodeficienciesTuberculosis PreventionImmunology	2016	95
Impact of Intermediate Hyperglycemia and Diabetes on Immune Dysfunction in Tuberculosis Clare Eckold, Vinod Kumar, January Weiner, Clinical Infectious Diseases	2020	71

Page 1